Pharmaceutical

FDA creates new priority review voucher scheme to boost US interests

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Jun 19, 2025 - 06:00
FDA creates new priority review voucher scheme to boost US interests
The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.
Read the original article

Tags:

Previous Article

Orion and Glykos extend ADC collaboration

Next Article

Lisata collaborates with GATC Health on drug development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Scientists inch closer to single-shot gene editing cure for blood disorders

STAT+: Scientists inch closer to single-shot gene editi...

Jul 28, 2023

STAT+: What to make of Biden’s latest Cancer Moonshot efforts

STAT+: What to make of Biden’s latest Cancer Moonshot e...

Sep 14, 2023

Opinion: U.S. medical schools aren’t teaching future doctors about 7.4 million of their patients

Opinion: U.S. medical schools aren’t teaching future do...

Dec 11, 2023